BioCentury
ARTICLE | Clinical News

TK regulatory update

March 31, 2014 7:00 AM UTC

MolMed said EMA accepted for review an MAA seeking conditional approval of TK as adjunctive treatment for high-risk leukemia patients undergoing hematopoietic stem cell transplantation (HSCT). MolMed ...